SCHEMBL4395967

SCHEMBL4395967

COC(=O)c1ccccc1OC(=O)Oc1ccccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.62
▸ LMNA P02545 1/20 0.62
▸ SLC6A3 Q01959 3/20 0.61
▸ HSD17B10 Q99714 3/20 0.56
▸ KDM4E B2RXH2 3/20 0.56
▸ HPGD P15428 2/20 0.56
▸ KMT2A Q03164 3/20 0.54
▸ HTT P42858 1/20 0.54
▸ MAPT P10636 1/20 0.52
▸ ALDH1A1 P00352 2/20 0.50
▸ POLB P06746 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ ESR1 P03372 1/20 0.50
▸ ESR2 Q92731 1/20 0.50
▸ PRSS1 P07477 1/20 0.49
▸ ACR P10323 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ SLC6A4 P31645 1/20 0.47
▸ CFTR P13569 1/20 0.47
▸ CA1 P00915 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Salicylate SCHEMBL26622127 0.93 LMNA (0.73) TSHRLMNASLC6A3HSD17B10KDM4E
SCHEMBL47893 0.91 SLC6A3 (0.71) TSHRLMNASLC6A3HSD17B10KDM4E
SCHEMBL29551673 0.91 SLC6A3 (0.71) TSHRLMNASLC6A3HSD17B10KDM4E
SCHEMBL7157094 0.91 LMNA (0.56) TSHRLMNASLC6A3HSD17B10KDM4E
SCHEMBL5706157 0.88 SLC6A3 (0.72) TSHRLMNASLC6A3HSD17B10KDM4E
SCHEMBL4393207 0.86 HSD17B10 (0.73) TSHRLMNASLC6A3HSD17B10KDM4E
SCHEMBL2442995 0.85 LMNA (0.76) TSHRLMNASLC6A3HSD17B10KDM4E
SCHEMBL1282392 0.83 SLC6A3 (0.66) TSHRLMNASLC6A3HSD17B10KDM4E
SCHEMBL4384566 0.83 SLC6A3 (0.61) TSHRLMNASLC6A3HSD17B10KDM4E
SCHEMBL4867511 0.82 KDM4E (0.61) TSHRLMNASLC6A3HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1829854-B1 PROCESS FOR PRODUCING AROMATIC CARBONATE ASAHI KASEI CHEMICALS CORP (JP) 2013-09-04 — — EP disclosed
US-7629485-B2 Process for producing aromatic carbonate ASAHI KASEI CHEMICALS CORPORATION (JP) 2009-12-08 — — US disclosed
US-20080177099-A1 Process for Producing Aromatic Carbonate ASAHI KASEI KABUSHIKI KAISHA (JP) 2008-07-24 — — US disclosed
EP-1829854-A1 PROCESS FOR PRODUCING AROMATIC CARBONATE Asahi Kasei Chemicals Corporation (JP) 2007-09-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080177099-A1 Process for Producing Aromatic Carbonate DCLK1, ALK, DCLK3 TSHR 4099/4885LMNA 2641/4885SLC6A3 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback